Insider Transactions in Q4 2018 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q4 2018)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 08
2018
|
Roger M Perlmutter Exe V-P & Pres, MRL |
SELL
Open market or private sale
|
Direct |
225,443
-61.43%
|
$16,908,225
$75.27 P/Share
|
Nov 08
2018
|
Roger M Perlmutter Exe V-P & Pres, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
225,443
+38.05%
|
$9,919,492
$44.98 P/Share
|
Nov 07
2018
|
Julie L. Gerberding EVP, Chief Patient Officer |
SELL
Open market or private sale
|
Direct |
36,218
-43.91%
|
$2,716,350
$75.14 P/Share
|
Nov 07
2018
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,218
+30.51%
|
$1,955,772
$54.68 P/Share
|
Nov 01
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
277,879
-73.89%
|
$20,285,167
$73.82 P/Share
|
Nov 01
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
277,879
+50.0%
|
$10,837,281
$39.29 P/Share
|
Oct 31
2018
|
Ashley Watson SVP Chief Ethics & Com Officer |
SELL
Open market or private sale
|
Direct |
47,036
-82.8%
|
$3,480,664
$74.33 P/Share
|
Oct 31
2018
|
Ashley Watson SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,036
+25.53%
|
$2,775,124
$59.5 P/Share
|
Oct 30
2018
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
25,467
-31.01%
|
$1,833,624
$72.0 P/Share
|
Oct 30
2018
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
25,467
+23.67%
|
$865,878
$34.19 P/Share
|
Oct 02
2018
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
279,850
-28.8%
|
$20,149,200
$72.07 P/Share
|
Oct 02
2018
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
279,850
+22.36%
|
$10,074,600
$36.56 P/Share
|